Last reviewed · How we verify
Donor IL-15 stimulated NK cells infusion
Donor IL-15 stimulated NK cells infusion is a Biologic drug developed by Martín, José Luis Díez, M.D.. It is currently in Phase 1 development.
At a glance
| Generic name | Donor IL-15 stimulated NK cells infusion |
|---|---|
| Sponsor | Martín, José Luis Díez, M.D. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Donor IL-15 stimulated NK cells infusion CI brief — competitive landscape report
- Donor IL-15 stimulated NK cells infusion updates RSS · CI watch RSS
- Martín, José Luis Díez, M.D. portfolio CI
Frequently asked questions about Donor IL-15 stimulated NK cells infusion
What is Donor IL-15 stimulated NK cells infusion?
Donor IL-15 stimulated NK cells infusion is a Biologic drug developed by Martín, José Luis Díez, M.D..
Who makes Donor IL-15 stimulated NK cells infusion?
Donor IL-15 stimulated NK cells infusion is developed by Martín, José Luis Díez, M.D. (see full Martín, José Luis Díez, M.D. pipeline at /company/mart-n-jos-luis-d-ez-m-d).
What development phase is Donor IL-15 stimulated NK cells infusion in?
Donor IL-15 stimulated NK cells infusion is in Phase 1.